SI2890777T1 - Farmacevtski sestavek, ki obsega pCMV-VEGF165, za stimulacijo angiogeneze - Google Patents

Farmacevtski sestavek, ki obsega pCMV-VEGF165, za stimulacijo angiogeneze

Info

Publication number: SI2890777T1
Authority: SI; Slovenia
Prior art keywords: vegf165; pcmv; angiogenesis; stimulation; pharmaceutical composition
Prior art date: 2012-08-31

Application number

SI201330595A

Other languages

English (en)

Inventor

Sergej L'vovich Kiselev

Roman Vadimovich Deev

Ivan Ivanovich Vorob'ev

Nadezhda Aleksandrovna Orlova

Artur Aleksandrovich Isaev

Original Assignee

"Nextgen" Company Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-08-31

Filing date

2013-08-02

Publication date

2017-06-30

2013-08-02 Application filed by "Nextgen" Company Limited filed Critical "Nextgen" Company Limited

2017-06-30 Publication of SI2890777T1 publication Critical patent/SI2890777T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Biophysics (AREA)
Oil, Petroleum & Natural Gas (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

SI201330595A 2012-08-31 2013-08-02 Farmacevtski sestavek, ki obsega pCMV-VEGF165, za stimulacijo angiogeneze SI2890777T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
RU2012137126/10A RU2542385C2 (ru)	2012-08-31	2012-08-31	Способ получения фармацевтической композиции для индукции развития кровеносных сосудов в тканях, фармацевтическая композиция, полученная этим способом, и способ лечения ишемии тканей и/или органов человека
PCT/RU2013/000669 WO2014035289A1 (en)	2012-08-31	2013-08-02	A pharmaceutical composition for stimulation of angiogenesis
EP13832746.5A EP2890777B1 (en)	2012-08-31	2013-08-02	A pharmaceutical composition comprising pcmv-vegf165 for stimulation of angiogenesis

Publications (1)

Publication Number	Publication Date
SI2890777T1 true SI2890777T1 (sl)	2017-06-30

Family

ID=50183970

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI201330595A SI2890777T1 (sl)	2012-08-31	2013-08-02	Farmacevtski sestavek, ki obsega pCMV-VEGF165, za stimulacijo angiogeneze

Country Status (13)

Country	Link
US (1)	US9616103B2 (sl)
EP (1)	EP2890777B1 (sl)
CN (1)	CN105308173B (sl)
BR (1)	BR112015002522B1 (sl)
CA (1)	CA2881799C (sl)
ES (1)	ES2621675T3 (sl)
HU (1)	HUE032520T2 (sl)
MX (1)	MX360980B (sl)
PL (1)	PL2890777T3 (sl)
RU (1)	RU2542385C2 (sl)
SI (1)	SI2890777T1 (sl)
WO (1)	WO2014035289A1 (sl)
ZA (1)	ZA201500909B (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2558294C1 (ru) *	2014-09-16	2015-07-27	Общество с ограниченной ответственностью "НекстГен"	Кодон-оптимизированная рекомбинантная плазмида, способ стимуляции регенерации периферического нерва, способ лечения поврежденного нерва человека
RU2612497C2 (ru)	2015-05-26	2017-03-09	Общество с ограниченной ответственностью "НекстГен"	Оптимизированная нуклеотидная последовательность и фармацевтическая композиция на ее основе с пролонгированной экспрессией трансгена vegf
RU2694826C1 (ru) *	2018-06-05	2019-07-17	Юрий Валентинович Червяков	Способ лечения хронической ишемии нижних конечностей атеросклеротического генеза при окклюзии артерий голени
EP3833244A4 (en) *	2018-08-08	2022-08-03	Brightspec, Inc.	LOW VOLATILITY SAMPLING METHODS AND APPARATUS
CN110760542B (zh) *	2019-11-18	2022-07-26	天津大学	一种共表达znf580和vegf165双基因的质粒及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998040508A1 (en) *	1997-03-14	1998-09-17	Selective Genetics, Inc.	Adenoviral vectors with modified tropism
US6627436B2 (en) *	1997-10-31	2003-09-30	Stratagene	Vector for gene expression in prokaryotic and eukaryotic systems
CN100471522C (zh) *	1998-03-13	2009-03-25	惠氏	聚核苷酸组合物及其制备方法与用途
WO2000047235A2 (en) *	1999-02-10	2000-08-17	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Methods of stimulating angiogenesis
US7087411B2 (en) *	1999-06-08	2006-08-08	Regeneron Pharmaceuticals, Inc.	Fusion protein capable of binding VEGF
US7288521B2 (en)	2000-04-06	2007-10-30	Franco Wayne P	Growth factor therapy mobilization of stem cells into the peripheral blood
CN1351055A (zh)	2000-10-26	2002-05-29	上海博德基因开发有限公司	一种新的多肽——人的血管内皮生长因子165受体(vegf－165r)10.67和编码这种多肽的多核苷酸
US7981863B2 (en) *	2001-09-19	2011-07-19	Neuronova Ab	Treatment of Parkinson's disease with PDGF
CN100431611C (zh)	2002-07-04	2008-11-12	朱静亚	多肽－脂质体与人血管内皮生长因子基因重组质粒复合物及用途
US7259149B2 (en) *	2002-12-02	2007-08-21	Anges Mg, Inc.	Methods for treating or preventing angiogenesis-dependent symptoms
EA011554B1 (ru) *	2004-09-17	2009-04-28	Сентелион	Стабильные жидкие композиции плазмидной днк
RU2297848C2 (ru) *	2005-05-11	2007-04-27	Александр Веньяминович Иткес	Генно-инженерная конструкция vegf-ибмед (vegf-ibmed)
ES2338400B1 (es)	2008-05-06	2011-09-14	David Benet Ferrus	Conjunto de moleculas antiangiogenicas y su uso.
US8367350B2 (en) *	2009-04-29	2013-02-05	Morehouse School Of Medicine	Compositions and methods for diagnosis, prognosis and management of malaria

2012
- 2012-08-31 RU RU2012137126/10A patent/RU2542385C2/ru active
2013
- 2013-08-02 PL PL13832746T patent/PL2890777T3/pl unknown
- 2013-08-02 WO PCT/RU2013/000669 patent/WO2014035289A1/en active Application Filing
- 2013-08-02 BR BR112015002522-6A patent/BR112015002522B1/pt active IP Right Grant
- 2013-08-02 CN CN201380045032.7A patent/CN105308173B/zh active Active
- 2013-08-02 ES ES13832746.5T patent/ES2621675T3/es active Active
- 2013-08-02 HU HUE13832746A patent/HUE032520T2/en unknown
- 2013-08-02 CA CA2881799A patent/CA2881799C/en active Active
- 2013-08-02 EP EP13832746.5A patent/EP2890777B1/en active Active
- 2013-08-02 SI SI201330595A patent/SI2890777T1/sl unknown
- 2013-08-02 MX MX2015002658A patent/MX360980B/es active IP Right Grant
- 2013-08-02 US US14/423,532 patent/US9616103B2/en active Active
2015
- 2015-02-09 ZA ZA2015/00909A patent/ZA201500909B/en unknown

Also Published As

Publication number	Publication date
CA2881799A1 (en)	2014-03-06
PL2890777T3 (pl)	2017-07-31
CN105308173B (zh)	2020-03-17
MX2015002658A (es)	2015-09-25
US9616103B2 (en)	2017-04-11
BR112015002522A2 (pt)	2017-11-07
HUE032520T2 (en)	2017-10-30
BR112015002522B1 (pt)	2022-04-05
MX360980B (es)	2018-11-22
EP2890777A4 (en)	2015-12-16
CA2881799C (en)	2019-10-29
EP2890777A1 (en)	2015-07-08
ES2621675T3 (es)	2017-07-04
EP2890777B1 (en)	2017-01-11
ZA201500909B (en)	2016-10-26
WO2014035289A1 (en)	2014-03-06
WO2014035289A9 (en)	2014-05-08
RU2012137126A (ru)	2014-03-10
RU2542385C2 (ru)	2015-02-20
US20150335711A1 (en)	2015-11-26
CN105308173A (zh)	2016-02-03

Publication	Publication Date	Title
ZA201703992B (en)	2019-12-18	Inhalable pharmaceutical compositions
HK1206297A1 (en)	2016-01-08	Pharmaceutical compositions for combination therapy
ZA201501930B (en)	2016-01-27	Pharmaceutical composition
EP2864361A4 (en)	2016-06-01	DOSAGE REGIME OF FUSION COMPOUNDS
EP2832730A4 (en)	2015-09-09	MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION
HRP20190050T1 (hr)	2019-03-08	Farmaceutski pripravci za kombinacijsku terapiju
ZA201405797B (en)	2015-08-26	Pharmaceutical dosage form
GB201205164D0 (en)	2012-05-09	Pharmaceutical compounds
ZA201501897B (en)	2016-10-26	A pharmaceutical composition
ZA201500909B (en)	2016-10-26	A pharmaceutical composition for stimulation of angiogenesis
HK1216619A1 (zh)	2016-11-25	藥物化合物
ZA201502987B (en)	2016-11-30	Pharmaceutical composition
EP2897590A4 (en)	2016-05-04	PHARMACEUTICAL COMPOSITION
GB201202027D0 (en)	2012-03-21	Pharmaceutical compounds
EP2851078A4 (en)	2015-10-21	PHARMACEUTICAL COMPOSITION
ZA201502354B (en)	2016-01-27	Pharmaceutical dosage form
PT2814473T (pt)	2019-01-21	Composições farmacêuticas para terapia de combinação
GB201221367D0 (en)	2013-01-09	A pharmaceutical composition
GB201219236D0 (en)	2012-12-12	Pharmaceutical compounds
ZA201400751B (en)	2014-12-25	Pharmaceutical composition
GB201214121D0 (en)	2012-09-19	Pharmaceutical compounds
GB201213519D0 (en)	2012-09-12	Pharmaceutical compounds
GB201221130D0 (en)	2013-01-09	New pharmaceutical composition
GB201203253D0 (en)	2012-04-11	Pharmaceutical compounds
GB201207701D0 (en)	2012-06-13	New pharmaceutical composition